From April 1, 2023 to June 30, 2023, the company has repurchased 6,879,600 shares, representing 1.21% for CNY 39.42 million. With this, the company has completed the repurchase of 14,523,100 shares, representing 2.57% for CNY 79.72 million under the buyback announced on July 15, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.04 CNY | -0.59% | -4.36% | -17.78% |
1st Jan change | Capi. | |
---|---|---|
-17.78% | 391M | |
+36.94% | 723B | |
+32.22% | 598B | |
-1.89% | 364B | |
+20.34% | 331B | |
+3.75% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+8.78% | 169B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Tranche Update on Henan Taloph Pharmaceutical Stock Co.,Ltd's Equity Buyback Plan announced on July 15, 2022.